Orthopedic device-related infections;Infecciones relacionadas con las prótesis articulares

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 6, 2008, Pages 380-390

  Ariza, Javier ^a   Euba, Gorane ^a   Murillo, Óscar ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Biofilms; Foreign body infection; Prosthetic joint

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; DAPTOMYCIN; FUSIDIC ACID; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; BACTEREMIA; BIOFILM; CLINICAL FEATURE; DEBRIDEMENT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG SENSITIVITY; EARLY DIAGNOSIS; ENTEROCOCCUS FAECALIS; HOST RESISTANCE; HUMAN; INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MICROORGANISM; PATHOGENESIS; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PREVALENCE; PROPIONIBACTERIUM ACNES; PROSTHESIOLOGY; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; PSEUDOMONAS AERUGINOSA; RADIODIAGNOSIS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS; SURGICAL TECHNIQUE;

EID: 45849130507     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13123843     Document Type: Article

References (50)

1. Tsukayama DT, Estrada R, Gustilo R. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg. 1996;78-A:512-23.
2. Steckelberg JM, Osmon DR. Prosthetic joint infections. En: Waldvogel FA, Bisno AL, editors. Infections associated with indwelling medical devices. 3rd ed. Washington: ASM Press; 2000. p. 173-209.
3. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
4. Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, et al. Future and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89:144-51.
5. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247-54.
6. Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36:1157-61.
7. Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly. 2005;125:243-51.
8. Berbari EF, Osmon DR, Duffy MCT, Harmssen RNW, Mandrekar JN, Hanssen AD, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis. 2006;42:216-23.
9. Murdoch DR, Roberts SA, Fowler VG, Shah MA, Taylor SL, Morris AJ, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis. 2001;32:647-9.
10. Vila J, Soriano A, Mensa J. Bases moleculares de la adherencia microbiana sobre los materiales protésicos. Papel de las biocapas en las infecciones asociadas a materiales protésicos. Enferm Infecc Microbiol Clin. 2008;26:48-55.
11. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990;162:96-102.
12. Rodríguez-Martínez JM, Pascual A. Actividad antibacteriana en biocapas bacterianas. Enferm Infecc Microbiol Clin. 2008;26:107-14.
13. Anwar H, Strap JL, Costerton JW. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother. 1992;36:1347-51.
14. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135-8.
15. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-93.
16. Sendi P, Rohrbach M, Graber P, Frei R, Ochsner PE, Zimmerli W. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis. 2006;43:961-7.
17. Zappe B, Graf S, Ochsner PE, Zimmerli W, Sendi P. Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge. Arch Orthop Trauma Surg. 2007; Sep 15 epub ahead of print.
18. Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, et al. Culture-negative prosthetic joint infection. Clin Infect Dis. 2007;45:1113-9.
19. Cobo J, García San Miguel L, Euba G, García-Lechuz JM, Pigrau C, Riera M, et al. Tratamiento conservador de las infecciones precoces sobre prótesis articulares. Comunicación no. 97, XIII Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), Madrid, mayo 2008.
20. Rodríguez D, Pigrau C, Euba G, Cabo J, García-San Miguel L, Cobo J, et al. Análisis multicéntrico y prospectivo del manejo médico-quirúrgico de la infección protésica aguda hematógena. Comunicación no. 103, XIII Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), Madrid, mayo 2008.
21. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo R. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg. 1999;81-A:1434-45.
22. Atkins BL, Athanasou N, Deeks JJ, Crook DWM, Simpson H, Peto T, et al (The Osiris Collaborative Study Group). Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol. 1998;36:2932-9.
23. Banit DM, Kaufer H, Hartford JM. Intraoperative frozen analysis in revision total joint arthroplasty. Clin Orthop. 2002;401:230-8.
24. Spanghel MJ, Masri BA, O'Conell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81:672-83.
25. Della Valle CJ, Sporer SM, Jacobs JJ, Berger RA, Rosenberg AG, Paprosky WG. Preoperative testing for sepsis before revision total knee arthroplasty. J Arthroplasty. 2007;22 Suppl 2:90-2.
26. El Espera I, Blondet C, Moullart V, Saidi L, Havet E, Mertl P, et al. The usefulness of 99mTc sulfur colloid bone marrow scintigraphy combined with 111In leucocyte scintigraphy in prostetic joint infection. Nucl Med Commun. 2004;25:171-5.
27. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med. 2004;117:556-62.
28. Senneville E, Savage C, Nallet I, Yazdanpanah Y, Giraud F, Migraud H, et al. Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 pateints and collected intraoperatively in Rosenow's broth. Acta Orthop. 2006;77:120-4.
29. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357:654-63.
30. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, et al. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol. 1999;37:3281-90.
31. McDowell A, Patrick S. Evaluation of nonculture methods for the detection of prosthetic hip biofilms. Clin Orthop Relat Res. 2005;437:74-82.
32. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, Steckelberg JM, Ilstrup DM, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthetic retention. Clin Infect Dis. 1997;24:914-9.
33. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006;42:471-8.
34. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother. 1993;37:1214-8.
35. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE, for the Foreign-Body Infection Study Group. Role of rifampin for treatment of orthopedic implant-related sthaphylococcal infections. A randomized controlled trial. JAMA. 1998;279:1537-41.
36. Soriano A, García S, Bori G, Almela M, Gallart X, Macule F, et al. Treatment of acute post-surgical infection joint arthroplasty. Clin Microbiol Infect. 2006;12:930-3.
37. Barberan J, Aguilar L, Carroquino G, Jiménez MJ, Sánchez B, Martínez D, et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med. 2006;119:993.e7-10.
38. Murillo O, Doménech A, García A, Tubau F, Cabellos C, Gudiol F, et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:4011-7.
39. Soriano A, Gómez J, Gómez L, Azanza JR, Pérez R, Romero F, et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis. 2007;26:353-6.
40. Meehan AM, Osmon DR, Duffy MCT, Hanssen AD, Keatin MR. Outcome of Penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2005; 36:845-9.
41. Bernard L, Hoffmeyer P, Assal M, Vadaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother. 2004;53:127-9.
42. Rao N, Crossett LS, Sinha RK, Le Frock JL. Long-term suppression of infection in total joint arthroplasty. Clin Orthop Rel Res. 2003;414:55-60.
43. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis. 2001;32:419-30.
44. Deirmengian C, Greenbaum BA, Lotke PA, Booth RE, Lonner JH. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty. 2003;18:22-6.
45. Saleh K, Callaghan J, Gioe T, Gross A, Holtzman J, Krackow K, et al. Septic joint replacement: an orthopaedic perspective. Clin Infect Dis. 2002;34:868-70.
46. Hanssen AD, Spangehl MJ. Treatment of the infected hip replacement. Clin Orthop Relat Res. 2004;420:63-71.
47. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79-85.
48. Murillo O, Euba G, Calatayud L, Domínguez MA, Verdaguer R, Pérez A, et al. Role for intraoperative cultures at the time of second-stage exchange managing infected total arthroplasty. Eur J Clin Microbiol Infect Dis. 2008 (en prensa).
49. García S, Soriano A, Esteban P, Almela M, Gallart X, Mensa J. Utilidad de la adición de antibióticos al cemento en el recambio en un tiempo de la infección crónica de artroplastia total de cadera. Med Clin (Barc). 2005;125:138-9.
50. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR. Prosthetic joint infection diagnosed postoperatively by intraoperative cultures. Clin Orthop Relat Res. 2005;439:38-42.